| pubmed-article:19103731 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19103731 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:19103731 | lifeskim:mentions | umls-concept:C0001779 | lld:lifeskim |
| pubmed-article:19103731 | lifeskim:mentions | umls-concept:C0040833 | lld:lifeskim |
| pubmed-article:19103731 | lifeskim:mentions | umls-concept:C1517925 | lld:lifeskim |
| pubmed-article:19103731 | lifeskim:mentions | umls-concept:C1521798 | lld:lifeskim |
| pubmed-article:19103731 | lifeskim:mentions | umls-concept:C0443196 | lld:lifeskim |
| pubmed-article:19103731 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19103731 | pubmed:dateCreated | 2009-2-9 | lld:pubmed |
| pubmed-article:19103731 | pubmed:abstractText | Guidelines recommend breast-conserving surgery (BCS) with radiation or mastectomy for definitive local therapy of stage I/II breast cancers. We assessed receipt of definitive local therapy for early-stage breast cancer by race/ethnicity and age and examined trends over time. | lld:pubmed |
| pubmed-article:19103731 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19103731 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19103731 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19103731 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19103731 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19103731 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19103731 | pubmed:author | pubmed-author:KeatingNancy... | lld:pubmed |
| pubmed-article:19103731 | pubmed:author | pubmed-author:WinerEric PEP | lld:pubmed |
| pubmed-article:19103731 | pubmed:author | pubmed-author:HeYuleiY | lld:pubmed |
| pubmed-article:19103731 | pubmed:author | pubmed-author:FreedmanRache... | lld:pubmed |
| pubmed-article:19103731 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19103731 | pubmed:day | 10 | lld:pubmed |
| pubmed-article:19103731 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:19103731 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19103731 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19103731 | pubmed:pagination | 713-9 | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:meshHeading | pubmed-meshheading:19103731... | lld:pubmed |
| pubmed-article:19103731 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19103731 | pubmed:articleTitle | Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. | lld:pubmed |
| pubmed-article:19103731 | pubmed:affiliation | Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. | lld:pubmed |
| pubmed-article:19103731 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19103731 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19103731 | lld:pubmed |
